Benzinga | Nov 23, 2020 04:01PM EST

Enanta Pharmaceuticals Q4 EPS $(1.46) Misses $(0.95) Estimate, Sales $23.63M Miss $25.74M Estimate

Enanta Pharmaceuticals (NASDAQ:ENTA) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(0.95) by 53.68 percent. This is a 431.82 percent decrease over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $23.63 million which missed the analyst consensus estimate of $25.74 million by 8.19 percent. This is a 53.95 percent decrease over sales of $51.31 million the same period last year.